User Guide
Why can I only view 3 results?
You can also view all results when you are connected from the network of member institutions only. For non-member institutions, we are opening a 1-month free trial version if institution officials apply.
So many results that aren't mine?
References in many bibliographies are sometimes referred to as "Surname, I", so the citations of academics whose Surname and initials are the same may occasionally interfere. This problem is often the case with citation indexes all over the world.
How can I see only citations to my article?
After searching the name of your article, you can see the references to the article you selected as soon as you click on the details section.
 Views 19
 Downloands 4
Parotis Bezinde Bazal Hücreli Adenokarsinom
2016
Journal:  
Pamukkale Tıp Dergisi
Author:  
Abstract:

Basal cell adenocarcinoma is low grade malignancy so named in 1990 by Ellis and Wiskovitch. The basal cell adenocarcinomas are rare, accounting for %1-2 of epithelial salivary malignancies. Roughly %77 arise de novo with %23 arising within preexisting basal cell adenomas. It is considered as the malign counterpart of the basal cell adenoma. Histological differentiation is between the two is difficult and they are often discriminated only by the invasion of local structures or perineural/vascular invasion. It is necessary to differentiate basal cell adenocarcinoma from other basaloid cell tumors of the salivary glands such as solid tubuler variant of adenoid cystic carcinoma, polymorphous low grade adenocarcinoma, basaloid type of squamous cell carcinoma, basaloid variant of ameloblastoma and small cell carcinoma for the prognosis and potential differences in the treatment. The standard treatment is wide local excision with or without postoperative radiotherapy.. In this article, we present a 75-year-old-female with basal cell adenocarcinoma involving the parotid gland.

Keywords:

Parotis Bezinde Basal Hucreli Adenocarcinoma
2016
Author:  
Abstract:

Basal cell adenocarcinoma is low grade malignancy so named in 1990 by Ellis and Wiskovitch. The basal cell adenocarcinomas are rare, accounting for 1-2% of epithelial salivary malignancies. Roughly 77% arise de novo with 23% arising within preexisting basal cell adenomas. It is considered as the malignant counterpart of the basal cell adenoma. Histological differentiation is between the two is difficult and they are often discriminated only by the invasion of local structures or perineural/vascular invasion. It is necessary to differentiate basal cell adenocarcinoma from other basaloid cell tumors of the salivary glands such as solid tubuler variant of adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, basaloid type of squamous cell carcinoma, basaloid variant of ameloblastoma and small cell carcinoma for the prognosis and potential differences in the treatment. The standard treatment is wide local excision with or without postoperative radiotherapy. In this article, we present a 75-year-old-woman with basal cell adenocarcinoma involving the parotid gland.

Keywords:

Citation Owners
Information: There is no ciation to this publication.
Similar Articles










Pamukkale Tıp Dergisi

Field :   Sağlık Bilimleri

Journal Type :   Uluslararası

Metrics
Article : 926
Cite : 1.203
© 2015-2024 Sobiad Citation Index